Sigma Genetics
Sigma Genetics, based in Seattle, WA, is a healthcare company specializing in non-invasive therapeutics technology that uses magnetic fields to deliver DNA, RNA, and other charged molecules into cells.
Overview of Sigma Genetics
Sigma Genetics is a healthcare company based in Seattle, WA, USA. The company specializes in developing devices that deliver DNA, RNA, and other charged molecules into cells using magnetic fields. Sigma Genetics operates within the therapeutics sub-industry and is part of the Y Combinator Winter 2017 batch. The company's technology is applicable to various fields such as cell therapies, cancer drug delivery, DNA vaccines, biopharma manufacturing, and cosmetics. They operate predominantly in the United States and Canada.
Technology and Innovations
Sigma Genetics employs a cutting-edge technique that uses magnetic fields to deliver DNA, RNA, and other charged molecules into cells. This method provides significant advantages, including the absence of arcing, scalability, and non-invasiveness, making it suitable for in vivo applications. The platform technology is versatile and can be applied in several areas, such as cell therapies, cancer drug delivery, DNA vaccines, biopharma manufacturing, and cosmetics.
Y Combinator W17 Batch Participation
Sigma Genetics participated in the Y Combinator Winter 2017 batch, gaining access to valuable resources, mentorship, and funding opportunities. Being part of Y Combinator's startup accelerator program has provided significant growth and development advantages, positioning the company well within the healthcare and therapeutics sector.
Locations and Team Size
Headquartered in Seattle, WA, Sigma Genetics operates within the United States and Canada. The team is notably small, consisting of just two members, reflecting its concentrated focus and specialized expertise in developing therapeutic technologies.
Applications of Sigma Genetics' Platform Technology
The platform technology developed by Sigma Genetics has a wide range of applications. It is particularly useful in cell therapies, offering a non-invasive method to introduce genetic material into cells. The technology is also employed in cancer drug delivery and DNA vaccines, where non-invasiveness and scalability are critical. Furthermore, it finds applications in biopharma manufacturing and the cosmetics industry, demonstrating its broad utility across various therapeutic and commercial fields.